☆ 4.5 Article

Impact of spontaneous liposome modification with phospholipid polymer-lipid conjugates on protein interactions

SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS (2022)

Related references

Note: Only part of the references are listed.

Article Materials Science, Biomaterials

Effect of liposome surface modification with water-soluble phospholipid polymer chain-conjugated lipids on interaction with human plasma proteins

Anna Adler et al.

Summary: Alternative liposome surface coatings with poly(2-methacryloyloxyethyl phosphorylcholine) (MPC)-based lipids (PMPC-lipids) can effectively suppress protein adsorption and C3 binding, especially with higher molecular weight and molar ratio of PMPC-lipids. Apolipoprotein A-I is detected on PMPC-liposomes with higher molecular weight, while alpha(2)-macroglobulin is detected on non-modified, PEGylated, and PMPC-liposomes with shorter polymer chains. There is a correlation among the PMPC molecular weight, molar ratio, and C3 binding.

JOURNAL OF MATERIALS CHEMISTRY B (2022)

Add to Collection

Review Pharmacology & Pharmacy

Polymer-Modified Liposomes for Drug Delivery: From Fundamentals to Applications

Yifeng Cao et al.

Summary: Polymer-modified liposomes have great advantages in drug delivery, improving drug release performance and enhancing therapeutic efficacy and safety.

PHARMACEUTICS (2022)

Add to Collection

Article Chemistry, Physical

Neutral polyphosphocholine-modified liposomes as boundary superlubricants

Weifeng Lin et al.

Summary: This study investigates the difference in surface lubricity between neutral lipid-PMPC conjugates and negatively charged lipid/polyphosphocholine conjugate modified liposomes. The results show that neutral polyphosphocholinated liposomes exhibit superlubricity, while negatively charged lipid/polyphosphocholine conjugate modified liposomes are unable to adsorb on negatively charged surfaces.

COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS (2022)

Add to Collection

Article Allergy

mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach

Aleena Banerji et al.

Summary: The FDA has authorized emergency use of Pfizer-BioNTech and Moderna COVID-19 vaccines, but individuals with severe allergic reactions are advised against receiving them. The CDC recommends observing those with a history of immediate allergies or anaphylaxis for 30 minutes post-vaccination, while all others should be observed for 15 minutes.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Add to Collection

Article Allergy

COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee

Paul J. Turner et al.

Summary: Vaccines against COVID-19 are crucial for controlling the pandemic, with most adverse events being a result of immune response rather than allergic reactions. Although anaphylaxis is rare with vaccines, recent data on reactions to the Pfizer-BioNTech vaccine suggest a closer incidence rate of 1 in 200,000 doses. A global surveillance strategy led by allergists is proposed to gather data and provide evidence-based guidance to public health bodies and the public for reassurance.

WORLD ALLERGY ORGANIZATION JOURNAL (2021)

Add to Collection

Letter Allergy

Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID-19 vaccine

Priya Sellaturay et al.

CLINICAL AND EXPERIMENTAL ALLERGY (2021)

Add to Collection

Review Pharmacology & Pharmacy

mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability

Linde Schoenmaker et al.

Summary: The current mRNA-lipid nanoparticle COVID-19 vaccines require storage at low temperatures due to instability. Improving mRNA nucleotide composition, understanding the impact of mRNA environment within LNPs, and exploring drying techniques can enhance vaccine stability.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)

Add to Collection

Article Materials Science, Biomaterials

Synthesis of poly(2-methacryloyloxyethyl phosphorylcholine)-conjugated lipids and their characterization and surface properties of modified liposomes for protein interactions

Anna Adler et al.

Summary: The study demonstrates that PMPC-lipids can be used for liposomal coating, suppressing the adsorption of albumin, C3, and fibrinogen, and potentially serving as an alternative to PEG.

BIOMATERIALS SCIENCE (2021)

Add to Collection

Article Pharmacology & Pharmacy

Blood retention and antigenicity of polycarboxybetaine-modified liposomes

Takaaki Ryujin et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)

Add to Collection

Review Engineering, Biomedical

Revolutionary advances in 2-methacryloyloxyethyl phosphorylcholine polymers as biomaterials

Kazuhiko Ishihara

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2019)

Add to Collection

Article Chemistry, Multidisciplinary

Poly-phosphocholinated Liposomes Form Stable Superlubrication Vectors

Weifeng Lin et al.

LANGMUIR (2019)

Add to Collection

Review Materials Science, Multidisciplinary

A human whole-blood model to study the activation of innate immunity system triggered by nanoparticles as a demonstrator for toxicity

Kristina N. Ekdahl et al.

SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS (2019)

Add to Collection

Review Materials Science, Multidisciplinary

PEGylated liposomes: immunological responses

Marwa Mohamed et al.

SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS (2019)

Add to Collection

Review Pharmacology & Pharmacy

Liposomal Formulations in Clinical Use: An Updated Review

Upendra Bulbake et al.

PHARMACEUTICS (2017)

Add to Collection

Article Chemistry, Multidisciplinary

Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation

Peng Zhang et al.

JOURNAL OF CONTROLLED RELEASE (2016)

Add to Collection

Article Materials Science, Multidisciplinary

Interaction of poly(ethylene glycol)-conjugated phospholipids with supported lipid membranes and their influence on protein adsorption

Toshihiro Yamamoto et al.

SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS (2016)

Add to Collection

Review Pharmacology & Pharmacy

Advances and Challenges of Liposome Assisted Drug Delivery

Lisa Sercombe et al.

FRONTIERS IN PHARMACOLOGY (2015)

Add to Collection

Review Pharmacology & Pharmacy

The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo

Hiroshi Maeda et al.

ADVANCED DRUG DELIVERY REVIEWS (2013)

Add to Collection

Review Pharmacology & Pharmacy

Liposomal drug delivery systems: From concept to clinical applications

Theresa M. Allen et al.

ADVANCED DRUG DELIVERY REVIEWS (2013)

Add to Collection

Review Nanoscience & Nanotechnology

Liposome: classification, preparation, and applications

Abolfazl Akbarzadeh et al.

NANOSCALE RESEARCH LETTERS (2013)

Add to Collection

Review Chemistry, Multidisciplinary

Doxil® - The first FDA-approved nano-drug: Lessons learned

Yechezkel (Chezy) Barenholz

JOURNAL OF CONTROLLED RELEASE (2012)

Add to Collection

Article Biochemistry & Molecular Biology

Liposome triggering of innate immune responses: A perspective on benefits and adverse reactions

Janos Szebeni et al.

JOURNAL OF LIPOSOME RESEARCH (2009)

Add to Collection

Article Biochemistry & Molecular Biology

Liposome-mediated triggering of complement cascade

S. Moein Moghimi et al.

JOURNAL OF LIPOSOME RESEARCH (2008)

Add to Collection

Review Biotechnology & Applied Microbiology

Recent advances with liposomes as pharmaceutical carriers

VP Torchilin

NATURE REVIEWS DRUG DISCOVERY (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.